Free Trial

BioNexus Gene Lab (BGLC) Institutional Ownership

$0.48
+0.00 (+1.01%)
(As of 11:44 AM ET)

Institutional Ownership Changes (13F Filings) for BioNexus Gene Lab (NASDAQ:BGLC)

Current
Institutional Ownership
Percentage
18.85%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$14.75K
Number of
Institutional Sellers
(last 12 months)
0
Get BGLC Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioNexus Gene Lab stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BioNexus Gene Lab Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/20/2024 Virtu Financial LLC47,037$33K0.0%+79.9%0.266%
(Data available from 1/1/2016 forward)

BGLC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BGLC shares?

During the previous two years, the following institutional investors and hedge funds held shares of BioNexus Gene Lab shares: Virtu Financial LLC ($33K).Learn more on BGLC's institutional investors.

What percentage of BioNexus Gene Lab stock is owned by institutional investors?

18.85% of BioNexus Gene Lab stock is owned by institutional investors. Learn more on BGLC's institutional investor holdings.

Which institutional investors have been buying BioNexus Gene Lab stock?

The following institutional investors have purchased BioNexus Gene Lab stock in the last 24 months: Virtu Financial LLC ($20.89K).

How much institutional buying is happening at BioNexus Gene Lab?

Institutional investors have bought a total of 20,888 shares in the last 24 months. This purchase volume represents approximately $14.75K in transactions.


This page (NASDAQ:BGLC) was last updated on 6/13/2024 by MarketBeat.com Staff

From Our Partners